Work

HSR25-174: Impact of Adverse Events on Quality of Life in Patients With Chronic Myeloid Leukemia Treated With Tyrosine Kinase Inhibitors – Results From the Survey on Humanistic Burden of Intolerance to First or Second TKIs (SHIFT) Study

Year: 2025

Type: article

Study design: Observational Study

Source: Journal of the National Comprehensive Cancer Network

DOI: 10.6004/jnccn.2024.7251

Authors: Kathryn E. Flynn, Joan Clements, Karen DeMairo, Jennifer Hiller, David Wei, Nisha C. Hazra, Cristina Constantinescu, Yan Meng, Dominick Latremouille-Viau, Kejal Jadhav, Gabriel Marquez, Daisy Yang, Andrea Damon, Islam Sadek, Annie Guérin, Kelly Schoenbeck

Institutions: Medical College of Wisconsin, Blood Cancer United, Novartis (Ireland), University of California, San Francisco

Language: English

Topic: Chronic Myeloid Leukemia Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4408959102

FWCI: 0.652

Cites:

Cited by: 1

Related to: 10